Company Profile
Belite Bio Stock Price, News & Analysis
- Ticker:
- BLTE
- Exchange:
- NASDAQ
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on NASDAQ, Belite Bio is followed within the biotech universe for its exposure to catalyst-driven execution.
Stock performance
145.09 USD (-1.35%)
Close
Last updated: June 23, 2026 at 00:00
5.82B USD
Market cap
Why the stock is moving
BLTE is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Belite Bio is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on NASDAQ, Belite Bio is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
Belite Bio follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, Belite Bio sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Belite Bio (BLTE)?
Belite Bio (BLTE) most recently closed at 145.09 USD, a -1.35% move versus the previous session.
What is the market cap of Belite Bio (BLTE)?
Belite Bio currently has a market capitalization of 5.82B USD on BioPharmSignal.
What does Belite Bio do?
Belite Bio is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is BLTE stock listed?
Belite Bio (BLTE) is associated with NASDAQ, Headquartered in the United States and listed on NASDAQ, Belite Bio is followed within the biotech universe for its exposure to catalyst-driven execution., Biotechnology.
What is Belite?
Belite Bio is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
Which conditions is Belite Bio targeting with Belite?
Belite Bio is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
What is Investors?
Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.